Cargando…

Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies

The COVID-19 pandemic poses major challenges to healthcare systems. We aimed to investigate the impact of the pandemic on prescription and adherence patterns of chronic cardiovascular therapies (lipid-lowering [LL], oral antidiabetic drugs [AD], and antihypertensives [AH]) using administrative pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casula, Manuela, Galimberti, Federica, Iommi, Marica, Olmastroni, Elena, Rosa, Simona, Altini, Mattia, Catapano, Alberico L., Tragni, Elena, Poluzzi, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566639/ https://www.ncbi.nlm.nih.gov/pubmed/36231403 http://dx.doi.org/10.3390/ijerph191912101

Ejemplares similares

Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study
por: Galimberti, Federica, et al.
Publicado: (2022)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
por: Olmastroni, Elena, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
por: Olmastroni, Elena, et al.
Publicado: (2023)

Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy
por: Galimberti, Federica, et al.
Publicado: (2022)

A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: design and rationale of the EDU.RE.DRUG study
por: Casula, Manuela, et al.
Publicado: (2020)

The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic
por: Galimberti, F., et al.
Publicado: (2022)

Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions—The EDU.RE.DRUG Project
por: Galimberti, Federica, et al.
Publicado: (2022)

Adherence to lipid-lowering treatment: the patient perspective
por: Casula, Manuela, et al.
Publicado: (2012)

The Effectiveness of Interventions to Evaluate and Reduce Healthcare Costs of Potentially Inappropriate Prescriptions among the Older Adults: A Systematic Review
por: Mucherino, Sara, et al.
Publicado: (2022)

Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study
por: Russo, Veronica, et al.
Publicado: (2020)

Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Correction: Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
por: Gazzotti, Marta, et al.
Publicado: (2022)

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group
por: Gazzotti, Marta, et al.
Publicado: (2023)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022)

Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions
por: Iommi, Marica, et al.
Publicado: (2020)

Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
por: Mattavelli, Elisa, et al.
Publicado: (2023)

Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting
por: Tragni, Elena, et al.
Publicado: (2021)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations
por: Mattavelli, Elisa, et al.
Publicado: (2022)

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022)

Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study
por: Messina, Rossella, et al.
Publicado: (2021)

Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database
por: Swart, Floor, et al.
Publicado: (2020)

Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia
por: Curia, Maria Cristina, et al.
Publicado: (2022)

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
por: Cicolari, Stefania, et al.
Publicado: (2021)

Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study
por: Cammarota, Simona, et al.
Publicado: (2013)

Emergency department accesses for diabetes-related complications during COVID-19 pandemic in people with type 2 diabetes and depression
por: Messina, Rossella, et al.
Publicado: (2022)

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease
por: Baragetti, Andrea, et al.
Publicado: (2020)

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
por: Mattavelli, Elisa, et al.
Publicado: (2021)

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2013)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2021)

Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN)
por: Baragetti, Andrea, et al.
Publicado: (2021)

Developing and validating an algorithm to identify incident chronic dialysis patients using administrative data
por: Gibertoni, Dino, et al.
Publicado: (2020)

Comparing risk adjustment estimation methods under data availability constraints
por: Iommi, Marica, et al.
Publicado: (2022)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study
por: Galai, Elisabetta, et al.
Publicado: (2022)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t8pb88fdl2plragjtgi304vkta